No — they're not the same thing. GLP-1 is a class of drugs (like saying "antibiotic"). Ozempic is one specific brand within that class (like saying "amoxicillin").
Think of it this way: GLP-1 drugs are like "SUVs." Ozempic is like a Toyota 4Runner — it's an SUV, but it's not the only one. There's also the Ford Explorer (Wegovy), the Chevy Tahoe (Mounjaro), and so on. They're all in the same category, but they're different products.
GLP-1 = the drug class (GLP-1 receptor agonists, named after the gut hormone they mimic)
Ozempic = one specific brand of semaglutide, made by Novo Nordisk, FDA-approved for type 2 diabetes
Ozempic became a household name around 2022–2023, largely driven by social media buzz about celebrities using it off-label for weight loss. The name stuck even though it's technically only approved for type 2 diabetes management. Meanwhile, Wegovy — which is the same drug (semaglutide) at a higher dose, actually approved for weight loss — is far less known by name.
The result: people say "Ozempic" when they really mean "GLP-1 medication for weight loss" — similar to saying "Kleenex" when you mean any tissue.
Here's a breakdown of the major GLP-1 medications currently available in the US:
| Brand Name | Active Ingredient | Approved For | How Taken |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | Weekly injection |
| Wegovy | Semaglutide (higher dose) | Weight loss (obesity) | Weekly injection |
| Rybelsus | Semaglutide | Type 2 diabetes | Daily pill |
| Mounjaro | Tirzepatide | Type 2 diabetes | Weekly injection |
| Zepbound | Tirzepatide (higher dose) | Weight loss (obesity) | Weekly injection |
| Victoza | Liraglutide | Type 2 diabetes | Daily injection |
| Saxenda | Liraglutide (higher dose) | Weight loss (obesity) | Daily injection |
Almost — but not quite. Both contain semaglutide, the same active ingredient. The difference is the dose and the approval. Ozempic tops out at 2mg weekly; Wegovy goes up to 2.4mg. More importantly, Ozempic is approved only for type 2 diabetes management, while Wegovy is specifically approved for chronic weight management in adults with obesity or overweight with a weight-related condition.
In practice, many doctors prescribe Ozempic "off-label" for weight loss, which is legal but was the source of significant supply shortages in 2022–2024 as demand exploded.
If weight loss is your primary goal, the clinical data points clearly to tirzepatide (Zepbound/Mounjaro) as the most effective option — with average weight loss around 20–22% of body weight in trials. Semaglutide (Wegovy/Ozempic) averages around 15%. See the full comparison →
GLP-1 and Ozempic are not the same thing. GLP-1 is the name of both a natural hormone and a class of medications that mimic it. Ozempic is just one of several brand-name drugs in that class. When people say "I'm thinking about getting on Ozempic," what they usually mean is "I'm considering a GLP-1 medication for weight loss" — and there are several options worth knowing about.
Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.
No spam ever. Unsubscribe anytime.
GLP1Authority.com is an independent review site. We may receive compensation when you click certain links. This does not influence our reviews or rankings. Always consult a healthcare provider before starting any medication. See our affiliate disclosure for details.
Not sure which GLP-1 program is right for you?
2 minutes. No email required.